Immunoadsorption for treatment of dilated cardiomyopathy;Immunadsorption als therapieverfahren der dilatativen kardiomyopathie

Internist

Volumn 49, Issue 1, 2008, Pages 51-56

  Felix, S B ^a   Dorr M ^a   Herda, L R ^a   Beug, D ^a   Staudt, A ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Cardiac antibodies; Dilated cardiomyopathy; Humoral immune system; Immunoadsorption; Myocardial inflammation

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN G3;

ANTIGEN ANTIBODY COMPLEX; CELLULAR IMMUNITY; CONGESTIVE CARDIOMYOPATHY; HEART FAILURE; HEART MUSCLE BIOPSY; HEMODYNAMICS; HUMAN; HUMORAL IMMUNITY; IMMUNOADSORPTION; IMMUNOCHEMISTRY; MYOCARDITIS; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; REVIEW;

CARDIOMYOPATHY, DILATED; CLINICAL TRIALS AS TOPIC; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOSORBENT TECHNIQUES; TREATMENT OUTCOME;

EID: 39649104543     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-007-1991-x     Document Type: Review

References (30)

1. Baba A, Yoshikawa T, Ogawa S (2002) Autoantibodies produced against sarcolemmal Na-K-ATPase: possible upstream targets of arrhythmias and sudden death in patients with dilated cardiomyopathy. J Am Coll Cardiol 40: 1153-1159
2. Bowles NE, Richardson PJ, Olsen EG, Archard LC (1986) Detection of coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1: 1120-1123
3. Caforio AL, Grazzini M, Mann JM et al. (1992) Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 85: 1734-1742
4. Codd MB, Sugrue DD, Gersh BJ, Melton LJ (1989) Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted Country, Minnesota, 1975-1984. Circulation 80: 564-572
5. Dörffel WV, Felix SB, Wallukat G et al. (1997) Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy. Circulation 95: 1994-1997
6. Feldman AM, McNamara DM (2000) Myocarditis. N Engl J Med 343: 1388-1398
7. Felix SB, Staudt A, Dörffel WV et al. (2000) Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study. J Am Coll Cardiol 35: 1590-1598
8. Felix SB, Staudt A, Landsberger M et al. (2002) Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption. J Am Coll Cardiol 39: 646-652
9. 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 113: 1419-1429
10. Kandolf R, Ameis D, Kirschner P et al. (1987) In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. Proc Natl Acad Sci U S A 84: 6272- 6276
11. Kühl U, Noutsias M, Schultheiss HP (1995) Immunohistochemistry in dilated cardiomyopathy. Eur Heart J (Suppl O) 16: 100-106
12. Kühl U, Pauschinger M, Seeberg B et al. (2005) Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112: 1965-1970
13. Lauer B, Schannwell M, Kuhl U et al. (2000) Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol 35: 11-18
14. Maron BJ, Towbin JA, Thiene G et al. (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113: 1807-1816
15. Matsui S, Fu ML, Katsuda S et al. (1997) Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits. J Mol Cell Cardiol 29: 641-655
16. McMurray JJ, Ostergren J, Swedberg K et al. CHARM Investigators and Committees (2003) Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin converting-enzyme inhibitors: the CHARM-Added trial. Lancet 362: 767-771
17. Müller J, Wallukat G, Dandel M et al. (2000) Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 101: 385-391
18. Nishimura H, Okazaki T, Tanaka Y et al. (2001) Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 291: 319-322
19. Nohria A, Lewis E, Stevenson LW (2002) Medical management of advanced heart failure. JAMA 287: 628-640
20. Noutsias M, Seeberg B, Schultheiss HP, Kühl U (1999) Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy. Circulation 99: 2124-2131
21. Okazaki T, Tanaka Y, Nishio R et al. (2003) Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat Med 9: 1477-1483
22. Pauschinger M, Bowles NE, Fuentes-Garcia FJ et al. (1999) Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 99: 1348-1354
23. Schultheiss HP, Kühl U, Janda I et al. (1988) Antibody-mediated enhancement of calcium permeability in cardiac myocytes. J Exp Med 168: 2105-2119
24. Staudt A, Böhm M, Knebel F et al. (2002) Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Circulation 106: 2448-2453
25. Staudt A, Eichler P, Trimpert C et al. (2007) Fc(gamma) receptors IIa on cardiomyocytes and their potential functional relevance in dilated cardiomyopathy. J Am Coll Cardiol 49: 1684-1692
26. Staudt A, Hummel A, Ruppert J et al. (2006) Immunoadsorption in dilated cardiomyopathy - six-month results from a randomized study. Am Heart J 152: 712.e1-6
27. Staudt A, Schäper F, Stangl V et al. (2001) Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation 103: 2681-2686
28. Staudt A, Staudt Y, Dörr M et al. (2004) Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy. J Am Coll Cardiol 44: 829-836
29. Staudt A, Staudt Y, Hummel A et al. (2006) Effects of immunoadsorption on the nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy. Ther Apher Dial 10: 42-48
30. Wallukat G, Wollenberger A, Morwinski R, Pitschner HF (1995) Anti-beta1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops. J Mol Cell Cardiol 27: 397-406